G9762 HPV Vaccine Series — HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS G9762: Adolescent HPV Vaccine Series Completion

HCPCS Level II code G9762 identifies completion of an adolescent human papillomavirus (HPV) vaccination series defined as either two doses separated by at least 146 days or three doses given between the patient’s 9th and 13th birthdays. Nationally, tracking and accurate reporting of this code matter for preventive care quality measures and immunization program monitoring, and it supports claims processing for vaccination services delivered in outpatient and community settings. Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise explanation of what G9762 represents, the clinical and administrative context for its use, and how it fits into adolescent preventive care workflows. The publication outlines common sites of service, typical billing considerations, and comparable codes or programmatic uses where available. It also highlights payer coverage patterns and coding implications relevant for claims submission, quality reporting, and vaccination program monitoring. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9762HCPCS Level IIHPV vaccineAdolescent immunizationPreventive careVaccination seriesOutpatient servicesQuality reportingImmunization registry

Billing Code Overview

HCPCS Level II code G9762 denotes that a patient received at least two HPV vaccines with at least 146 days between doses, or three HPV vaccines administered on or between the patient's 9th and 13th birthdays. This code documents completion of the adolescent HPV vaccination series according to the specified timing criteria.

Service type: Immunization administration / Preventive vaccination series
Typical site of service: Outpatient clinics, pediatrician or family medicine offices, community health centers, school-based health centers

Clinical & Coding Specifications

Clinical Context

A 12-year-old adolescent presents to a pediatric primary care clinic for routine immunizations during a well-child visit. The patient previously received an initial human papillomavirus (HPV) vaccine at age 10 and returned for a second dose 150 days later; the clinician documents completion of the 2-dose series given the interval of at least 146 days between doses. The immunization is recorded in the electronic medical record, the vaccine manufacturer and lot number are documented, and the visit note indicates counseling provided to the parent on HPV protection. Billing staff assign the HCPCS Level II preventive care measure code G9762 to indicate the patient had at least two HPV vaccines (with at least 146 days between the two) or three HPV vaccines administered between the patient’s 9th and 13th birthdays. Typical workflow steps include verification of prior vaccination dates, administration of the vaccine if indicated, documentation of lot and consent, updating the immunization registry, and submission of the claim with the appropriate modifier when applicable. Typical site of service is outpatient ambulatory clinics (pediatrician or family medicine office) or community health centers providing routine adolescent immunizations.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when additional work or complexity for counseling/documentation significantly exceeds usual for the immunization visit.

HCPCS G9966: Developmental, Behavioral, and Social Risk Screening with Report

HCPCS-G8559-OTOLOGIC-EVALUATION-REFERRAL

HCPCS G8559: Referral for Otologic Evaluation

HCPCS-G2214-PSYCHIATRIC-COLLABORATIVE-CARE-MANAGEMENT-30-MIN

HCPCS G2214: Psychiatric Collaborative Care Management, First 30 Minutes

HCPCS-G0425-TELEHEALTH-ED-INITIAL-INPATIENT-30MIN-CONSULT

HCPCS G0425: Telehealth Consultation, ED or Initial Inpatient, 30 Minutes

HCPCS-G8850-POSITIVE-AIRWAY-PRESSURE-THERAPY-NOT-PRESCRIBED

HCPCS G8850: Positive Airway Pressure Therapy Not Prescribed

HCPCS-LEVEL-II-G9723-HOSPICE-SERVICES-DURING-MEASUREMENT-PERIOD

HCPCS Level II G9723: Hospice Services During Measurement Period

HCPCS-G0384-LEVEL-5-HOSPITAL-EMERGENCY-DEPARTMENT-VISIT

HCPCS G0384: Level 5 Hospital Emergency Department Visit

HCPCS-G8667-UPPER-EXTREMITY-IMPAIRMENT-RESIDUAL-SCORE-ZERO-OR-GREATER

HCPCS G8667: Residual Score for Elbow, Wrist or Hand Impairment

HCPCS-G2132-FRAILTY-WITH-DEMENTIA-MEDICATION

HCPCS G2132: Frailty with Dispensed Dementia Medication

HCPCS-G6048-DIMETHADIONE-MEDICATION

HCPCS G6048: Dimethadione Medication

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207Q00000X`	Pediatrics	Primary specialty delivering adolescent immunizations.
`208000000X`	Family Medicine	Common outpatient site for routine HPV vaccination.
`363LP0800X`	Public Health/Community Health	Clinics and health centers administering school-age immunizations.
`208D00000X`	General Practice	Smaller practices that provide routine vaccination services.
`352600000X`	Nurse Practitioner	NPs commonly administer and document immunizations in ambulatory settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z23`	Encounter for immunization	Primary diagnosis code used to indicate administration of vaccine or immunization services.
`Z28.2`	Immunization not carried out because of patient’s decision for reasons of belief or group negative	Used if patient/guardian declines HPV vaccination.
`Z71.89`	Other specified counseling	Used when significant vaccine counseling is provided during the visit.
`Z00.129`	Encounter for routine child health examination without abnormal findings	Commonly used for well-child visits at which vaccines are administered.
`Z00.121`	Encounter for routine child health examination with abnormal findings	Used if the well-child visit includes abnormal findings requiring follow-up during the immunization visit.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`90460`	Immunization administration through 18 years of age, first or only component of each vaccine or toxoid administered (includes counseling)	Used when administering the first vaccine component during a visit that includes counseling; often billed alongside vaccine product codes (when applicable) during HPV immunization visits.
`90461`	Immunization administration through 18 years of age, each additional vaccine component administered	Used when multiple vaccines are given during the same encounter in addition to the primary vaccine.
`90651`	Human papillomavirus vaccine, quadrivalent (types 6, 11, 16, 18), 3-dose schedule, for intramuscular use	One of the vaccine product codes that may be administered in an HPV series; relates to product administered when billing vaccine supply (if billed separately).
`90649`	Human papillomavirus vaccine, bivalent (types 16, 18), 3-dose schedule, for intramuscular use	Alternative HPV vaccine product code that may be used depending on product given.
`90650`	Human papillomavirus vaccine, 9-valent (HPV9), 3-dose schedule, for intramuscular use	Common HPV product for adolescents; used when documenting the specific vaccine product in the immunization series.
`99384`	Initial comprehensive preventive medicine evaluation, early adolescent (11-14 years)	Preventive visit code commonly billed for the well-child visit during which HPV vaccination and series completion are assessed.

OpenPayer